CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 94 filers reported holding CTI BIOPHARMA CORP in Q4 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $260,000 | -46.1% | 488,611 | +24.6% | 0.00% | 0.0% |
| Q4 2015 | $482,000 | +10.3% | 392,003 | +30.9% | 0.00% | 0.0% |
| Q3 2015 | $437,000 | -25.4% | 299,489 | -0.3% | 0.00% | 0.0% |
| Q2 2015 | $586,000 | +18.9% | 300,489 | +10.2% | 0.00% | 0.0% |
| Q1 2015 | $493,000 | -25.2% | 272,637 | -2.3% | 0.00% | -50.0% |
| Q4 2014 | $659,000 | +10.0% | 279,137 | +12.7% | 0.00% | +100.0% |
| Q3 2014 | $599,000 | -12.9% | 247,679 | +1.1% | 0.00% | -50.0% |
| Q2 2014 | $688,000 | – | 244,873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 44,796,940 | $16,767,000 | 3.16% |
| Nine Chapters Capital Management LLC | 24,900 | $9,000 | 0.06% |
| FIRST NEW YORK SECURITIES LLC /NY | 53,100 | $19,875,000 | 0.01% |
| JW Asset Management, LLC | 50,254 | $19,000 | 0.01% |
| WASHINGTON TRUST Co | 410,616 | $154,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 919,200 | $344,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 37,284 | $14,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 82,880 | $31,000 | 0.00% |
| Modera Wealth Management, LLC | 25,000 | $9,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 526,210 | $195,000 | 0.00% |